Cargando…
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
BACKGROUND: Treatment with a combination of PD-1 and CTLA-4 targeted checkpoint inhibition has improved outcome of melanoma patients and led to durable remissions but is also associated with significant toxicities. Endocrinopathies such as thyroiditis and hypophysitis are often seen, but other, rare...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385398/ https://www.ncbi.nlm.nih.gov/pubmed/30791949 http://dx.doi.org/10.1186/s40425-019-0528-x |